Electrome 100,000 Unit Order Impact:
1. Reaching the "Magic Number" and "Copper" ($0.01 PPS)
The Impact: A 100,000-unit order obliterates the $250,000 profit threshold. At a conservative wholesale price of $20 per unit, 100,000 units generate $2.0M in gross revenue.
The Mechanism: Because BIEL has been downsized to a lean, 4-employee operation with minimal fixed overhead, the gross margins on this single order will instantly generate the $250K net profit needed for Phase 1.
The Market Reaction: As investors price in this massive backlog, speculative volume will flood the 24.7B share float, easily driving the stock past the $0.003 "story stock" breakout point toward $0.01.
2. Sustaining the Path to $0.04 and $0.08 PPS (2027)
Tax-Shielded Profits: The $41M tax-loss carryforward means BIEL keeps 100% of the operating profits from the Electrome order.
Milestone Acceleration: As these 100,000 units are manufactured and shipped through late 2026 and early 2027, the $2.0M in total revenue fully satisfies the Phase 2 ($1M profit) milestone. However, to clear the Phase 3 ($2M profit) milestone entirely from this single partnership, BIEL will rely on initial follow-on reorders or ultra-low production COGS to bridge the gap.
3. Achieving "GOAT" Status ($0.10 PPS by 2028)
The Math: To hit $0.10 PPS, BIEL needs $2.5M in pure profit. Because the initial order caps out at $2.0M in gross revenue, hitting this target requires the initial 100,000-unit deployment to successfully trigger international reorders and wider commercial adoption to secure the remaining baseline net income.
The Valuation: At a $2.5M profit and a growth-justified P/E ratio, the market cap scales to ~$2.47 Billion. The initial 100,000-unit order acts as the real-world proof-of-concept that turns a $0.0001 micro-cap into a historic 100,000%+ appreciation story, putting it past the historical timelines of Monster and Apple.
Additional revenue should come in from Taiwan, veterinary, the $500K 2024/2025 revenue base, etc.
1. Reaching the "Magic Number" and "Copper" ($0.01 PPS)
The Impact: A 100,000-unit order obliterates the $250,000 profit threshold. At a conservative wholesale price of $20 per unit, 100,000 units generate $2.0M in gross revenue.
The Mechanism: Because BIEL has been downsized to a lean, 4-employee operation with minimal fixed overhead, the gross margins on this single order will instantly generate the $250K net profit needed for Phase 1.
The Market Reaction: As investors price in this massive backlog, speculative volume will flood the 24.7B share float, easily driving the stock past the $0.003 "story stock" breakout point toward $0.01.
2. Sustaining the Path to $0.04 and $0.08 PPS (2027)
Tax-Shielded Profits: The $41M tax-loss carryforward means BIEL keeps 100% of the operating profits from the Electrome order.
Milestone Acceleration: As these 100,000 units are manufactured and shipped through late 2026 and early 2027, the $2.0M in total revenue fully satisfies the Phase 2 ($1M profit) milestone. However, to clear the Phase 3 ($2M profit) milestone entirely from this single partnership, BIEL will rely on initial follow-on reorders or ultra-low production COGS to bridge the gap.
3. Achieving "GOAT" Status ($0.10 PPS by 2028)
The Math: To hit $0.10 PPS, BIEL needs $2.5M in pure profit. Because the initial order caps out at $2.0M in gross revenue, hitting this target requires the initial 100,000-unit deployment to successfully trigger international reorders and wider commercial adoption to secure the remaining baseline net income.
The Valuation: At a $2.5M profit and a growth-justified P/E ratio, the market cap scales to ~$2.47 Billion. The initial 100,000-unit order acts as the real-world proof-of-concept that turns a $0.0001 micro-cap into a historic 100,000%+ appreciation story, putting it past the historical timelines of Monster and Apple.
Additional revenue should come in from Taiwan, veterinary, the $500K 2024/2025 revenue base, etc.
2
